Comparing safety of proton‐pump inhibitors versus H2‐receptor antagonists in kidney transplant recipients: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparing safety of proton‐pump inhibitors versus H2‐receptor antagonists in kidney transplant recipients: A systematic review and meta‐analysis

Published:2021-12-20 Issue: Volume: Page:
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Mohammadi Keyhan¹^ORCID,Yaribash Shakila²,Razi Bahman³,Dashti‐Khavidaki Simin¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran

2. Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran

3. Department of Hematology and Blood Banking School of Medicine Tarbiat Modares University Tehran Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13589

Reference33 articles.

1. Kidney transplantation across a positive crossmatch: a single‐center experience;Santos C;Transplant Proc,2014

2. Changes in quality of life after renal transplantation;Overbeck I;Transplant Proc,2005

3. Gastrointestinal complications after kidney transplantation;Gioco R;World J Gastroenterol,2020

4. Proton pump inhibitors, but not H2‐receptor antagonists, are associated with incident fractures among kidney transplant recipients;Lyu B;Transplantation,2020

5. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease;Arora P;BMC Nephrol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials;Current Pharmaceutical Design;2024-02

2. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study;BMJ Open;2024-01

3. Side effects of gastrointestinal drugs;Side Effects of Drugs Annual;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3